A detailed history of Fiera Capital Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Fiera Capital Corp holds 2,807 shares of NVO stock, worth $294,903. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,807
Previous 3,032 7.42%
Holding current value
$294,903
Previous $432,000 22.69%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$119.07 - $145.42 $26,790 - $32,719
-225 Reduced 7.42%
2,807 $334,000
Q2 2024

Aug 01, 2024

SELL
$122.71 - $146.91 $252,291 - $302,046
-2,056 Reduced 40.41%
3,032 $432,000
Q1 2024

Aug 22, 2024

BUY
$102.11 - $135.92 $209,938 - $279,451
2,056 Added 67.81%
5,088 $653,000
Q1 2024

May 01, 2024

BUY
$102.11 - $135.92 $55,649 - $74,076
545 Added 12.0%
5,088 $653,000
Q4 2023

Aug 22, 2024

SELL
$87.78 - $105.45 $160,549 - $192,868
-1,829 Reduced 28.7%
4,543 $469,000
Q4 2023

Feb 08, 2024

SELL
$87.78 - $105.45 $160,549 - $192,868
-1,829 Reduced 28.7%
4,543 $469,000
Q3 2023

Aug 22, 2024

BUY
$90.94 - $199.54 $303,739 - $666,463
3,340 Added 110.16%
6,372 $579,000
Q3 2023

Nov 09, 2023

BUY
$90.94 - $199.54 $407,865 - $894,936
4,485 Added 237.68%
6,372 $579,000
Q2 2023

Aug 09, 2023

SELL
$155.98 - $172.65 $107,314 - $118,783
-688 Reduced 26.72%
1,887 $305,000
Q1 2023

Apr 26, 2023

BUY
$132.34 - $159.14 $89,594 - $107,737
677 Added 35.67%
2,575 $409,000
Q4 2022

Feb 08, 2023

BUY
$102.55 - $135.33 $194,639 - $256,856
1,898 New
1,898 $256,000
Q3 2018

Nov 13, 2018

SELL
$46.76 - $51.24 $223,653 - $245,080
-4,783 Closed
0 $0
Q1 2018

May 11, 2018

SELL
$48.49 - $58.14 $3,830 - $4,593
-79 Reduced 1.62%
4,783 $236,000
Q4 2017

Feb 09, 2018

SELL
$47.53 - $53.73 $12,167 - $13,754
-256 Reduced 5.0%
4,862 $261,000
Q3 2017

Nov 13, 2017

BUY
$41.15 - $49.22 $210,605 - $251,907
5,118
5,118 $246,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Fiera Capital Corp Portfolio

Follow Fiera Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Fiera Capital Corp with notifications on news.